CA15.3, CEA and LDH in Dogs with Malignant Mammary Tumors

Journal of Veterinary Internal Medicine

Volumn 26, Issue 6, 2012, Pages 1383-1388

  Campos, L C ^a   Lavalle, G E ^a   Estrela Lima, A ^b   Melgaco de Faria J C ^a   Guimaraes J E ^b   Dutra, A P ^c   Ferreira, E ^a   de Sousa, L P ^a   Rabelo, E M L ^a   Vieira da Costa, A F D ^a   Cassali, G D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Female dog; Mammary gland; Neoplasia; Tumor marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CARCINOMA; CASE CONTROL STUDY; CLASSIFICATION; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADENOCARCINOMA; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; L-LACTATE DEHYDROGENASE; MAMMARY NEOPLASMS, ANIMAL; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 84869795191     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.01014.x     Document Type: Article

References (28)

1. Gion M, Daidone MG. Circulating biomarkers from tumor bulk to tumor machinery: Promises and pitfalls. Eur J Cancer 2004;40:2613-2622.
2. Eisenberg ALA, Koifman S. Breast cancer: Tumor markers. Rev Bras Canc 2001;47:377-388.
3. Jacobs EL, Haskell MC. Clinical use of tumor markers in oncology. Curr Prob Cancer 1991;15:299-360.
4. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007: Update of recommendations for the use tumor markers in breast cancer. J Clin Oncol 2007;25:5287-5312.
5. Molina R, Barak V, Dalen A, et al. Tumor markers in breast cancer - European Group on Tumor Markers recommendations. Tumor Biol 2005;26:281-293.
6. Almeida JRC, Pedrosa NL, Leite JB, et al. Tumor markers: A literature review. Rev Bras Canc 2007;53:305-316.
7. Souza JV. Marker mucinous cancer associated. Rev AMRIGS 2002;46:70-83.
8. von Kleist S, Migule I, Halla B. Possible function of CEA as cell-contact inhibitory molecule. Anticancer Res 1995;15:1889-1894.
9. Cheung KL, Graves CRL, Robertson JFR. Tumor marker measurements in the diagnostics, monitoring of breast cancer. Cancer Treat Rev 2000;26:91-102.
10. Duffy M, Duggan C, Keane R, et al. High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: Study of 600 patients with histologically confirmed breast cancer. Clin Chem 2004;50:559-563.
11. Marchesi MC, Manuali E, Pacifico E, et al. Cancer antigen 15/3: Possible diagnostic use in veterinary clinical oncology. Preliminary study. Vet Res Commun 2010;34:103-106.
12. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9:425-434.
13. Koukourakis M, Giatromanolaki A, Sivridis E, et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Brit J Cancer 2003;89:877-885.
14. Peleteiro MC. Tumores mamários na cadela e na gata. Rev Port Cien Vet 1994;89:10-34.
15. Cassali GD, Gobbi H, Malm C, Schimitt FC. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: Comparative features with human tumours. Cytopathology 2007;18 :191-196.
16. Misdorp W. Malignant Mammary tumors in the dog and cat. In: Mouton, DJ Tumors in Domestic Animals, 4th ed. IA: Blackwell; 2002:589-606.
17. Cavalcanti MF, Cassali GD. Fatores prognósticos no diagnóstico clínico e histopatológico dos tumores de mama em cadelas- revisão. Rev Clin Vet 2006;61:56-63.
18. Perez-Alenza Md, Peña L, Del Castillo N, et al. Factors influencing the incidence and prognosis of canine mammary tumors. J Small Anim Pract 2000;41:287-291.
19. Misdorp W, Else RW, Hellmén E, Limpscomb TP. Histological Classification of Mammary Tumors of the Dog and the Cat. Washington D.C.: World Health Organization; 1999;7:11-25.
20. Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals, 5th ed. San Diego: Academic Press; 1997:646-879.
21. Safi F, Kohler I, Rottinger E, Beger HG. The value of the tumor marker CA15.3 in diagnosing and monitoring breast cancer. Cancer 1991:574-582.
22. Balint E, Manolescu N, Braslasu D, et al. Molecular detection through CEA (carcino-embrionic-antigen) of different types of cancer in animal. Lucrǎri Stiintifice Medicinǎ Veterinarǎ 2008;51:89-93.
23. Waisberg J, Landman G, Cha ASH, et al. Standard of the tecidual distribution of the CEA in the carcinoma col-retal: Relation with the serico level of the CEA and sorting of Dukes. Rev Bras Colo-proctol 2002;22:20-26.
24. Shawn RC, Kevin LB, Bryant SA, et al. Comparative study of four serological tumor markers for the detection of breast cancer. J Miss Acad Sci 2002;47:126-128.
25. Magro AM, Bento RS. Tumour markers. Med Int 1997;4:189-196.
26. Carvalho JLBD. Serum lactate dehydrogenase in neoplastic disease. Pediatria 1993;15:38-40.
27. Giatromanolaki A, Sivridis E, Gatter KC, et al. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol 2006;103:912-918.
28. Manuali E, De Giuseppe A, Feliziani F, et al. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Vet Res 2012;8:86.